T. Rowe Price Associates’s DermTech, Inc. Common Stock DMTK Stock Holding History

T. Rowe Price Associates’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,510	Closed	-$337K	–	3053
2021 Q3	$337K	Buy	+10,510	New	+$369K	﹤0.01%	2538
2020 Q3	–	Sell	-121,225	Closed	-$1.6M	–	2635
2020 Q2	$1.6M	Sell	121,225 -212,108	-64%	-$2.76M	﹤0.01%	1601
2020 Q1	$3.56M	Buy	+333,333	New	+$4.09M	﹤0.01%	1386

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

T. Rowe Price Associates's DMTK Position: Q4 2021 in Review

T. Rowe Price Associates sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2021, closing a stake of 10,510 shares — an estimated $337K sold.

T. Rowe Price Associates first reported a position in DMTK in Q1 2020 and held it in 3 quarters. The position peaked at $3.56M in Q1 2020. 143 funds tracked by Wall St. Rank hold DMTK as of Q4 2021.

T. Rowe Price Associates reported no remaining DermTech, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
T. Rowe Price Associates sold 10,510 DermTech, Inc. Common Stock shares in Q4 2021, an estimated $337K.
T. Rowe Price Associates first reported a position in DermTech, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
T. Rowe Price Associates's DermTech, Inc. Common Stock position peaked at $3.56M in Q1 2020.
143 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2021.

Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.